PharmaShots | Incisive News in 3 Shots

Subscribe Now

Rare Pediatric Disease

Novartis' Iptacopan (LNP023) Receives the US FDA's Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G

Novartis' Iptacopan (LNP023) Receives the US FDA's Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation...

December 16, 2020

ProQR's Sepofarsen Receives FDA's Rare Pediatric Disease Designation to Treat Leber's Congenital Amaurosis 10

ProQR's Sepofarsen Receives FDA's Rare Pediatric Disease Designation to Treat Leber's Congenital Amaurosis 10

October 16, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us